Amir Gharib1 ,
Zohreh Faezizadeh1,
Masoud Godarzee2
1Department of Laboratory Sciences, Borujerd Branch, Islamic Azad University, Borujerd, Iran;
2Department of Biology, Borujerd Branch, Islamic Azad University, Borujerd, Iran.
For correspondence:- Amir Gharib
Email: amirgharib@gmail.com Tel:+986623500201
Received: 22 October 2014
Revised: 16 January 2015
Published: 28 February 2015
Citation:
Gharib A, Faezizadeh Z, Godarzee M.
Preparation and characterization of nanoliposomal beta-cryptoxanthin and its effect on proliferation and apoptosis in human leukemia cell line K562. Trop J Pharm Res 2015; 14(2):187-194
doi:
10.4314/tjpr.v14i2.1
© 2015 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Abstract
Purpose:To prepare beta-cryptoxanthin-loaded nanoliposomes and evaluate their anti-proliferative activity in leukemia K562 cell line, compared to free beta-cryptoxanthin.
Methods:Beta-cryptoxanthin-loaded nanoliposomes were prepared by extrusion method. Morphological characterization of the nanoliposomes was performed by cryo-transmission electron microscopy (cryo-TEM). The anti-proliferation effect of beta-cryptoxanthin (BC) in free and liposomal forms on K562 cell line was studied using 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide assay. Apoptotic activity, following treatment with beta-cryptoxanthin in the free and liposomal forms, was detected using flow cytometry.
Results:Entrapment efficiency of beta-cryptoxanthin was 86.3 % ± 1.0. Cryo-TEM analysis revealed that the nanoliposomes have spherical shapes. In all conditions, beta-cryptoxanthin-loaded nanoliposomes exhibited greater anti-proliferative activity than than the free beta-cryptoxanthin (p < 0.001). Furthermore, in the presence of beta-cryptoxanthin-loaded nanoliposomes, the proportion of apoptotic cells was higher for free beta-cryptoxanthin (p < 0.001).
Conclusion:The data obtained indicate that beta-cryptoxanthin, especially in the liposomal form, inhibits the growth of K562 cells and may therefore provide a basis for the development of leukemia therapies.
Keywords: Beta-cryptoxanthin, Nanoliposome, Anti-proliferative, Apoptosis, Flow cytometry, Leukemia